BIJUVA

About TherapeuticsMD

Founded in 2008, TherapeuticsMD was established to advance the science and standardization of bio-identical hormone therapy for women's health. The company achieved significant milestones with the FDA approval of three novel products for menopause and contraception, most notably the long-acting contraceptive ring ANNOVERA. In 2022, facing commercial and financial challenges, the company executed a strategic pivot, selling its prescription business to Mayne Pharma for up to $140 million and transitioning to a royalty-based business model focused on its licensed intellectual property.

Therapeutic Areas